Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1875 of 2228 entries
View as:

Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis

Phase: N/A Priority: Normal
NCT ID: NCT02233920 Org: User:
Start: 01/31/00 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02211963 Org: User:
Start: 02/28/07 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 10773 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02172170 Org: User:
Start: 01/31/07 End: - Due: -

A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

Phase: N/A Priority: Normal
NCT ID: NCT00240474 Org: User:
Start: 12/31/02 End: 03/31/04 Due: 03/31/05

Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT05402020 Org: User:
Start: 09/30/22 End: 02/13/23 Due: 02/13/24

Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02788474 Org: User:
Start: 06/09/16 End: 06/08/18 Due: 06/08/19

12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales

Phase: N/A Priority: Normal
NCT ID: NCT02172378 Org: User:
Start: 05/31/00 End: - Due: -

12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)

Phase: N/A Priority: Normal
NCT ID: NCT00144196 Org: User:
Start: 03/11/04 End: 07/25/05 Due: 07/25/06

Jardiance® Post Marketing Surveillance (PMS) in Korean Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT05236673 Org: User:
Start: 07/28/22 End: 04/30/25 Due: 04/30/26

Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02238158 Org: User:
Start: 09/30/99 End: - Due: -

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT01979952 Org: User:
Start: 11/26/13 End: 10/27/16 Due: 10/27/17

Relative Bioavailability of Olodaterol and Fluconazole

Phase: N/A Priority: Normal
NCT ID: NCT01153724 Org: User:
Start: 05/31/10 End: - Due: -

A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD

Phase: N/A Priority: Normal
NCT ID: NCT01525615 Org: User:
Start: 02/29/12 End: 09/30/13 Due: 09/30/14

A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT04801693 Org: User:
Start: 05/26/21 End: 04/25/22 Due: 04/25/23

A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed

Phase: N/A Priority: Normal
NCT ID: NCT02722135 Org: User:
Start: 11/30/16 End: 09/30/18 Due: 09/30/19

A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)

Phase: N/A Priority: Normal
NCT ID: NCT04147234 Org: User:
Start: 08/03/20 End: 03/21/24 Due: 03/21/25

Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02221414 Org: User:
Start: 01/31/10 End: - Due: -

A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

Phase: N/A Priority: Normal
NCT ID: NCT06214741 Org: User:
Start: 02/06/24 End: 01/30/26 Due: 01/30/27

Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02242253 Org: User:
Start: 09/30/03 End: - Due: -

A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05213624 Org: User:
Start: 05/03/22 End: 01/03/25 Due: 01/03/26

Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01795937 Org: User:
Start: 02/28/13 End: 03/31/13 Due: 03/31/14

Bioavailability of Two Sustained-release Theophylline Products in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT02184247 Org: User:
Start: 04/30/98 End: - Due: -

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

Phase: N/A Priority: Normal
NCT ID: NCT01328184 Org: User:
Start: 04/30/11 End: - Due: -

Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel

Phase: N/A Priority: Normal
NCT ID: NCT01941615 Org: User:
Start: 11/30/13 End: 01/31/14 Due: 01/31/15

A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies

Phase: N/A Priority: Normal
NCT ID: NCT06878365 Org: User:
Start: 06/16/25 End: 12/07/26 Due: 12/07/27